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Abstract
The role of protein tyrosine kinases on glutamate release was investigated by determining the effect of broad range inhibitors of tyrosine
kinases on the release of glutamate from rat hippocampal synaptosomes. We found that lavendustin A and herbimycin A did not inhibit
glutamate release stimulated by 15 mM KCl, but genistein, also a broad range inhibitor of tyrosine kinases did inhibit the intracellular Ca2+
concentration response to KCl and, concomitantly, decreased glutamate release evoked by the same stimulus, in a dose-dependent manner.
These effects were not observed with the inactive analogue genistin. Therefore, we investigated the mechanism whereby genistein modulates
Ca2+ influx and glutamate release. Studies with voltage-gated Ca2+ channel inhibitors showed that -conotoxin GVIA did not further
inhibit glutamate release or the Ca2+ influx stimulated by KCl in the presence of genistein. This tyrosine kinase inhibitor and -agatoxin
IVA had a partially additive effect on those events. Nitrendipine did not reduce significantly the KCl-induced responses. Genistein further
reduced Ca2+ influx in response to KCl in the presence of nitrendipine, -conotoxin GVIA and -agatoxin IVA, simultaneously. The
effect of tyrosine phosphatase inhibitors was also tested on the influx of Ca2+ and on glutamate release stimulated by KCl-depolarization.
We found that the broad range inhibitors sodium orthovanadate and dephostatin did not significantly affect these KCl-evoked events.
Our results suggest that genistein inhibits glutamate release and Ca2+ influx in response to KCl independently of tyrosine kinase
inhibition, and that tyrosine kinases and phosphatases are not key regulators of glutamate release in hippocampal nerve terminals.
© 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Protein tyrosine kinases are highly expressed in several
brain regions, including the hippocampus, being particu-
larly enriched in synaptic membrane and synaptic vesicle
fractions (Hirano et al., 1988; Lev et al., 1995; Ellis et al.,
2000). This suggests that tyrosine phosphorylation may play
a role in hippocampal synaptic plasticity. In fact, tyrosine
kinase activity is involved in the induction of long-term
potentiation (LTP) in hippocampus (O’Dell et al., 1991).
The level of tyrosine phosphorylated proteins does not de-
pend solely on the activity of tyrosine kinases but are the
result of a tight balance between tyrosine kinase and ty-
rosine phosphatase activity. Protein-tyrosine phosphatases,
also expressed in adult hippocampus (Van Vactor, 1998),
can positively or negatively regulate tyrosine kinase activ-
ity which, on the other hand, may also modulate tyrosine
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phosphatase activity (reviewed in Petrone and Sap, 2000;
Ostman and Bohmer, 2001).
Both tyrosine kinases and phosphatases can exist as inte-
gral membrane proteins, known as receptor tyrosine kinases
(RTK) and receptor protein-tyrosine phosphatases (RPTP),
or as cytosolic proteins. Brain derived neurotrophic factor
(BDNF), a neurotrophin that binds to TrkB, a RTK, has been
extensively described to act on hippocampal synaptic plastic-
ity (Levine et al., 1995; Patterson et al., 1996; Leßmann and
Heumann, 1998; Jovanovic et al., 2000). Cytosolic tyrosine
kinases like c-src, proline-rich tyrosine kinase 2 (PYK2),
c-fyn and pp125FAK may also be involved in synaptic plas-
ticity (for review see Gurd, 1997). On the other hand, the ac-
tivity of these cytosolic proteins can be regulated by RPTPs
like CD45 and RPTP (Petrone and Sap, 2000).
Although, the modulation of ion channel activity by
phosphorylation is usually associated to serine/threonine
kinases and phosphatases, an equally important role for
tyrosine phosphorylation has been emerging (reviewed in
Siegelbaum, 1994; Gurd, 1997). Tyrosine kinase activity
increases voltage-gated Ca2+ channel (VGCC) activity
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(Cataldi et al., 1996; Potier and Rovira, 1999), reduces
K+ channel currents (Huang et al., 1993; Lev et al., 1995;
Holmes et al., 1996), and enhances N-methyl-d-aspartate
(NMDA) channel currents (Wang and Salter, 1994; Gurd,
1997). This suggests that tyrosine kinases may contribute
to an overall increase in neuronal excitability. However,
a recent report showed that tyrosine phosphorylation is a
negative regulator of Na+ channel activity (Ratcliffe et al.,
2000).
Synaptic vesicle proteins and other proteins involved in
exocytosis may also be targets for tyrosine phosphorylation,
suggesting new mechanisms for the modulation of synaptic
plasticity by tyrosine kinases and phosphatases (Pang et al.,
1988; Jovanovic et al., 1996; Janz et al., 1999). The synap-
tic vesicle proteins synaptophysin and synaptotagmin seem
to have an important function in hippocampal short- and
long-term plasticity, although the physiological relevance of
tyrosine phosphorylation of these proteins is still unclear
(Janz et al., 1999). Synapsin I, a protein associated to synap-
tic vesicles, is involved in the modulation of glutamate re-
lease by BDNF, probably through phosphorylation of the
protein by the mitogen activated protein kinase (MAPK), one
of the effectors of TrkB signaling (Jovanovic et al., 2000).
Since depolarization of nerve endings increases tyrosine
phosphorylation (Woodrow et al., 1992; Siciliano et al.,
1996; Barrie et al., 1996), and taking into account that ty-
rosine kinases and phosphatases may modulate ion channel
function and the activity of the exocytotic machinery, we in-
vestigated a role for tyrosine kinase activity in the modula-
tion of glutamate release from hippocampal synaptosomes.
2. Experimental procedures
2.1. Materials
The acetoxymethyl ester of Indo-1 (Indo-1/AM), the
broad range protein molecular weight standards, and
the sypro orange protein gel stain were purchased from
Molecular Probes Europe BV (Leiden, The Netherlands).
Ionomycin, fatty acid-free bovine serum albumin (BSA),
lavendustin A and dephostatin were obtained from
Calbiochem–Novabiochem International (La Jolla, CA).
Genistein and genistin were from Sigma and herbimycin A
was from Biomol Research Labs Inc. (Plymouth Meeting,
PA). The VGCC inhibitors -agatoxin IVA and -conotoxin
GVIA were obtained from Peptide Institute Inc. (Osaka,
Japan). Nitrendipine was from Research Biochemicals In-
ternational (Natick, MA). Reagents used in immunoblotting
experiments were purchased from Bio-Rad (Hercules, CA).
The polyvinylidene difluoride (PVDF) membranes, the al-
kaline phosphatase-linked anti-mouse secondary antibody,
the enhanced chemifluorescence (ECF) reagent and Per-
coll were obtained from Amersham Pharmacia Biotech
(Buckinghamshire, England). The anti-phosphotyrosine
antibody was a kind offer from New England Biolabs
(Beverly, MA). All other reagents were from Sigma or from
Merck.
2.2. Isolation of crude (P2) and purified hippocampal
synaptosomal fractions
The crude synaptosomal P2 fraction from male Wistar rat
hippocampi was isolated as described elsewhere (McMahon
et al., 1992) with minor modifications. Briefly, 6–8 week
old animals were sacrificed by cervical dislocation and their
hippocampi were dissected and homogenized (5%, w/v) in
0.32 M sucrose, 10 mM HEPES, pH 7.4 (sucrose buffer),
using a Thomas B homogenizer. The suspension was cen-
trifuged at 3000×gmax, for 2 min, and the supernatants were
spun at 14,600×gmax, for 12 min. The upper white layer
of the pellet (P2), containing the majority of the synapto-
somes, was removed and resuspended in sucrose buffer at
a protein concentration of about 8–12 mg/ml, as determined
by the Biuret method (Layne, 1957). Alternatively, a puri-
fied hippocampal synaptosomal suspension was isolated us-
ing the Percoll method described elsewhere (Dunkley et al.,
1988) with some modifications. The crude synaptosomal P2
fraction was resuspended in sucrose buffer and layered on
top of Percoll discontinuous gradients consisting of layers of
sucrose buffer containing 23, 10 and 3% Percoll. After cen-
trifugation at 23,200×gmax, for 5 min, the purified synapto-
somal fraction was removed from the interface between the
23 and 10% Percoll solutions, and resuspended in 15 vol-
umes of sucrose buffer. The synaptosomal suspension was
spun twice at 20,000×gmax, for 20 min, and resuspended in
sucrose buffer at a protein concentration of 4.0–5.5 mg/ml, as
determined by the bicinchoninic acid (BCA) method (Smith
et al., 1985). The synaptosomes (purified or crude fraction)
were stored on ice as drained pellets and used within 4 h.
The whole procedure was performed at 0–4 ◦C.
2.3. Glutamate release
The release of endogenous glutamate was measured us-
ing a continuous fluorimetric assay, based on the reduction
of NADP+ catalyzed by glutamate dehydrogenase (GDH,
EC 1.4.1.3) in the presence of glutamate (Nicholls et al.,
1987). In short, synaptosomes (1 mg protein/ml) were incu-
bated for 20 min, at 30 ◦C, in incubation medium (1 ml of
132 mM NaCl, 1 mM KCl, 1 mM MgCl2, 1.2 mM H3PO4,
0.1 mM CaCl2, 10 mM glucose, 10 mM HEPES-Na+, pH
7.4) supplemented with 0.1 mg/ml fatty-acid-free BSA.
After centrifugation at 15,800×gmax, for 20 s, the synap-
tosomes were resuspended in reaction medium (similar to
the incubation medium but without BSA, and containing
either 1 mM CaCl2 or 200 nM Ca2+ [50M EGTA; 38M
CaCl2] for Ca2+-independent glutamate release measure-
ments). NADP+ (1 mM, final concentration) and GDH
(40 U) were added, and fluorescence was measured using
excitation and emission wavelengths of 340 and 460 nm,
with 5 and 10 nm slits, respectively. The experiments were
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conducted at 37 ◦C, under continuous stirring, and the cali-
bration was performed at the end of each experiment with
2.5 nM of glutamate. When tyrosine kinase/phosphatase
inhibitors, -agatoxin IVA and -conotoxin GVIA were
tested, they were present both in incubation and in reaction
medium. Nitrendipine, a lipophylic drug, binds rapidly to
L-type Ca2+ channels and therefore was added only in the
reaction medium.
2.4. Intracellular [Ca2+]i measurements
The [Ca2+]i was determined by measuring the ratio of
Indo-1/Ca2+ complex fluorescence at two distinct emission
wavelengths, essentially as described previously (Duarte
et al., 1996). Briefly, synaptosomes (1.5 mg protein/ml) were
loaded with Indo-1 at 25 ◦C for the first 20 min, followed
by 10 min at 35 ◦C, in incubation medium containing 3M
Indo-1/AM. The synaptosomes were spun and resuspended
at 0.375 mg protein/ml in reaction medium containing
1 mM CaCl2. Incubation with tyrosine kinase/phosphatase
inhibitors and/or VGCC inhibitors was performed as de-
scribed for glutamate release experiments. When depho-
statin was tested, Fura-2 was used instead of Indo-1 since
this drug interfered with Indo-1 fluorescence. Fluorescence
was monitored at 30 ◦C, under continuous stirring, at the
excitation wavelength of 335 nm and emission wavelengths
of 410 and 485 nm, for Indo-1, and excitation wavelengths
of 340 and 380 nm and emission wavelength of 505 nm, for
Fura-2. Five nm slits were used. Calibration was performed
at the end of each experiment with 2.5M ionomycin fol-
lowed by 20 mM Tris/4 mM EGTA (final concentrations),
to determine the maximal fluorescence and the autofluores-
cence, respectively. Fluorescence intensities were converted
into [Ca2+]i using the calibration equation for double emis-
sion wavelength measurements (Grynkiewicz et al., 1985).
2.5. Immunoblotting
Purified synaptosomes (3.5 mg protein/ml) were pre-
incubated, for 20 min at 30 ◦C, in incubation medium, fol-
lowed by incubation in reaction medium (containing either
1 mM CaCl2 or 200 nM free Ca2+), at 37 ◦C, for 5 min,
or for 4 min followed by 1 min stimulation with 15 mM
KCl. The reaction was stopped by adding 2× concentrated
sample buffer [100 mM Tris, 100 mM glycine, 4% sodium
dodecyl sulfate (SDS), 8% -mercaptoethanol, 8 M urea
and 3 mM sodium orthovanadate] and heating the samples
for 5 min at 95 ◦C. Equal amounts of protein (25g) were
separated by electrophoresis on 10% SDS-poliacrylamide
gels (SDS-PAGE), and transferred electrophoretically to
PVDF membranes. The membranes were then blocked for
1 h at room temperature, in Tris-buffered saline [137 mM
NaCl, 20 mM Tris–HCl, pH 7.6] containing 0.1% Tween-20
(TBS-T) and 5% low fat milk. The membranes were
incubated overnight at 4 ◦C, with a mouse monoclonal
anti-phosphotyrosine antibody diluted 1:2000 in TBS-T
with 5% BSA. Alternatively, the antibody was incubated
with phosphothreonine, phosphoserine or phosphotyro-
sine prior to membrane probing, to assess for antibody
specificity. After extensive washing, membranes were incu-
bated with alkaline phosphatase-linked anti-mouse serum
(1:20,000 in TBS-T with 5% low fat milk) for 1 h at room
temperature. Protein immunoreactive bands were visualized
by ECF on a Storm 860 Gel and Blot Imaging System
(Amersham Pharmacia Biotech), following incubation of
the membranes with ECF reagent for 5 min.
2.6. Statistical analysis
Results are presented as means±S.E.M. of the indicated
number of experiments. Statistical significance was deter-
mined using one-way ANOVA followed by Newman–Keuls
or Dunnett post tests, as indicated.
3. Results
3.1. KCl-depolarization induces tyrosine phosphorylation
of synaptosomal proteins in a Ca2+-dependent manner
In order to determine the content in phosphotyrosine
residues in synaptosomal proteins and tyrosine phos-
phorylation changes in response to depolarization, im-
munoblotting assays were performed using a monoclonal
anti-phosphotyrosine antibody. As depicted in Fig. 1A,
there are several tyrosine phosphorylated proteins in control
conditions, in purified hippocampal nerve terminals. The
specificity of the phosphotyrosine antibody was tested by
previously incubating the antibody with phosphotyrosine,
phosphothreonine or phosphoserine (Fig 1B). Depolariza-
tion of the nerve terminals with 15 mM KCl, for 1 min,
increased the tyrosine phosphorylation of two proteins
of approximately 107 and 44 kDa (Fig. 1, arrowheads).
K+-depolarization of nerve terminals in a low Ca2+ reaction
medium (200 nM free Ca2+) did not induce tyrosine phos-
phorylation of synaptosomal proteins (Fig. 1A), suggesting
Ca2+ influx as a key factor for tyrosine kinase activation
following depolarization.
3.2. Protein tyrosine kinase inhibitors have contradictory
effects on glutamate release and [Ca2+]i increase in
response to KCl-depolarization of hippocampal nerve
terminals
Taking into account that several synaptic proteins are
tyrosine phosphorylated and that this phosphorylation in-
creases following K+-depolarization, we investigated a
role for tyrosine kinases on the release of glutamate from
hippocampal synaptosomes. Therefore, we studied the ef-
fect of genistein, lavendustin A and herbimycin A, three
broad spectrum inhibitors of tyrosine kinases (Akiwama
et al., 1987; Onoda et al., 1989; Akiwama and Ogawara,
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Fig. 1. Effect of KCl-depolarization on the phosphotyrosine content of synaptosomal proteins. (A) Representative membranes showing phosphotyrosine
immunoreactivity of protein extracts from synaptosomal suspensions in control conditions, or following stimulation with 15 mM KCl for 1 min (KCl), as
described in Section 2. Comparison between control and KCl-stimulated phosphotyrosine signals were done in reaction medium containing either 1 mM
CaCl2 or 200 nM free Ca2+ (EGTA). Arrowheads depict differences in intensity between bands in lanes 1 and 2, corresponding to proteins of approximately
107 and 44 kDa. (B) Immunoreactivity against anti-phosphotyrosine antibody incubated or not (Ctr) with phosphotyrosine (PY), phosphothreonine (PT)
or phosphoserine (PS) peptides prior to membrane probing.
1991; Uehara and Fukazawa, 1991), on the release of glu-
tamate evoked by KCl-depolarization. Synaptosomes were
pre-incubated with the tyrosine kinase inhibitors for 20 min
and the depolarization-evoked glutamate release was then
monitored also in the presence of the inhibitors. Basal glu-
tamate release was measured for 4 min and KCl-stimulated
release was followed for the next 5 min. As depicted in
Fig. 2A, the different tyrosine kinase inhibitors had con-
trasting effects on glutamate release. Genistein showed a
concentration-dependent inhibitory effect on the release of
glutamate in response to KCl-depolarization. At a concen-
tration of 100M, genistein decreased glutamate release to
38.9 ± 3.2% of the control. Genistin, an inactive analogue
of genistein (Akiwama and Ogawara, 1991), did not af-
fect the release of glutamate evoked by K+-depolarization,
suggesting that the effect of genistein on glutamate release
was specific. However, lavendustin A and herbimycin A
had no significant effect on glutamate release when used
at concentrations known to inhibit tyrosine kinase activity
(Onoda et al., 1989; Uehara and Fukazawa, 1991; Satoh
et al., 1992) (Fig. 2A).
The Ca2+-independent release of glutamate, which is
attributed to the reversal of the glutamate transporter
(Nicholls, 1989), was measured by depolarizing the synap-
tosomes with 15 mM KCl in a medium containing 200 nM
free Ca2+. The Ca2+-independent release under these ex-
perimental conditions was 40.1 ± 0.9% of the control.
Genistein, at 100M, had no significant effect on the
Ca2+-independent glutamate release (36.2 ± 0.3% of the
control, P > 0.05, Dunnett comparison test). These results
suggest that genistein inhibits the Ca2+-dependent release
of glutamate. The other tyrosine kinase inhibitors had also
no significant effect on the Ca2+-independent release of
glutamate (lavendustin A, 10M, 41.3± 2.2%, P > 0.05;
herbimycin A, 10M, 38.3 ± 2.6%, P > 0.05, Dunnett
test).
Since genistein reduced the Ca2+-dependent glutamate re-
lease, we investigated whether this effect could be attributed
to an inhibition of the [Ca2+]i increase evoked by plasma
membrane depolarization. Incubation of the nerve terminals
with genistein decreased both the basal [Ca2+]i and the ini-
tial [Ca2+]i increase in response to KCl, in a dose-dependent
manner (Fig. 2B and C). At 100M, genistein significantly
reduced the basal [Ca2+]i to 68.6 ± 2.0% of the control
(Fig. 2B), and inhibited the [Ca2+]i response to 15 mM
KCl to 32.9 ± 2.6% of the control (Fig. 2C). Genistin, at
100M, did not affect significantly the basal [Ca2+]i nor the
[Ca2+]i rise evoked by KCl (Fig. 2B and C). The other tyro-
sine kinase inhibitors were also tested and although laven-
dustin A was without effect on the basal [Ca2+]i and on
the [Ca2+]i response to depolarization (Fig. 2B and C), her-
bimycin A slightly reduced the [Ca2+]i increase stimulated
by KCl (Fig. 2C). At the concentration of 10M, herbimycin
A reduced the [Ca2+]i response to K+-depolarization to
76.0±3.3% of the control (Fig. 2C). Incubation of the nerve
terminals with higher concentrations of herbimycin A did
not further inhibit KCl-induced [Ca2+]i increase (data not
shown). Interestingly, this extent of [Ca2+]i inhibition by
herbimycin A is quite similar to the inhibition caused by
10M genistein, which also had no significant effect on
glutamate release at that concentration.
3.3. Genistein and ω-agatoxin IVA show partially additive
inhibitory effects on glutamate release and on the [Ca2+]i
response to KCl
In order to further understand the effect of genistein on
Ca2+ influx, a comparative study using VGCC inhibitors and
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Fig. 2. Effect of protein tyrosine kinase inhibitors on glutamate release and
[Ca2+]i increase evoked by KCl. (A) Effect of genistein (Gen), genistin
(Gin), lavendustin A (LavA) and herbimycin A (HerbA) on total glutamate
release evoked by 15 mM KCl. The concentrations used for each inhibitor
are expressed in M, under the correspondent bar, except for genistin that
was used at 100M. Results are expressed as a percentage of the control
response ± S.E.M., of 3–4 experiments performed in different prepara-
tions. Glutamate release in control conditions was 5.02 ± 0.23 nM/mg
protein/5 min (n = 19). (B) Effect of the protein tyrosine kinase inhibitors
mentioned earlier on the basal [Ca2+]i of hippocampal synaptosomes.
Results are expressed as mean % of the control ± S.E.M. for n = 3–5.
In control conditions, the basal [Ca2+]i was 258.2± 9.1 nM (n = 28). C,
Effect of protein tyrosine kinase inhibitors on the initial [Ca2+]i response
to 15 mM KCl. The changes in [Ca2+]i ([Ca2+]i) were calculated as
the difference between the peak values following depolarization and the
basal values acquired just prior to the stimulus. In control conditions, the
[Ca2+]i induced by 15 mM KCl was 285.8 ± 10.9 nM (n = 28). The
results are expressed as mean % control± S.E.M. Statistical significance
was determined by one-way ANOVA followed by Dunnett comparison
test performed for each condition as compared to the correspondent con-
trol response in the absence of all drugs (∗∗P < 0.01).
genistein was performed, both on the release of glutamate
and on the [Ca2+]i increase stimulated by KCl.
The L-type VGCC inhibitor nitrendipine (Duarte et al.,
1996), at a concentration of 1M, had no significant effect
on the KCl-evoked glutamate release (Fig. 3A), and caused
only a minor decrease in the correspondent [Ca2+]i rise, to
92.0 ± 1.9% of the control (n = 6, P < 0.05, Dunnett
comparison test; Fig. 3B). Nitrendipine had also no effect on
the basal [Ca2+]i (96.2 ± 2.0% of the control, n = 6, P >
0.05, Dunnett test). Co-application of 50M genistein and
1M nitrendipine did not further inhibit glutamate release
and the [Ca2+]i response to 15 mM KCl, as compared to the
effect of genistein on its own.
The contribution of the N-type VGCC in the events
studied was assessed using the N-type VGCC inhibitor
-conotoxin GVIA (-CgTx GVIA) (Duarte et al., 1996).
Pre-incubation of the nerve terminals with 500 nM -CgTx
GVIA lead to a reduction of the [Ca2+]i response to
KCl-depolarization, to 77.2 ± 2.6% of the control (n = 4,
P < 0.01, Dunnett test), and a concomitant decrease in
glutamate release, to 89.4 ± 2.4% of the control (n = 6,
P < 0.05, Dunnett test) (Fig. 3A and B), without affect-
ing the resting [Ca2+]i (91.5 ± 4.5%, n = 4, P > 0.05,
Dunnett test). When -CgTx GVIA and genistein were
applied together, the inhibition of glutamate release and
the [Ca2+]i rise following K+-depolarization was not sig-
nificantly different from the effect of genistein alone. The
N-type VGCC inhibitor had no significant effect on the
resting [Ca2+]i (91.5 ± 4.5%, n = 4, P > 0.05, Dunnett
test).
The P-/Q-type VGCC inhibitor -agatoxin IVA (-Aga
IVA) (Duarte et al., 1996), at a concentration of 100 nM, in-
hibited the [Ca2+]i response to KCl, to 50.9±3.2% (n = 6,
P < 0.01, Dunnett test), and caused a reduction in gluta-
mate release, to 42.0 ± 3.6% of the control (n = 7, P <
0.05, Dunnett test) (Fig. 3A and B). The basal [Ca2+]i was
also inhibited by -Aga IVA to 86.2 ± 2.6% of the con-
trol (n = 6, P < 0.01, Dunnett test). The P-/Q-type VGCC
inhibitor further reduced glutamate release and the [Ca2+]i
rise following KCl-depolarization in the presence of genis-
tein, but the effect of both drugs was only partially additive
(Fig. 3A and B). To determine whether the ability of -Aga
IVA to further reduce these events in the presence of genis-
tein was due to the use of a submaximal concentration of
this drug (see Figs. 2 and 3), the same study was performed
using 100M genistein. The toxin -Aga IVA was again
able to further inhibit the [Ca2+]i response to KCl under
these conditions (data not shown).
The simultaneous inhibition of L-, N- and P-/Q-type of
VGCC, using all of the earlier mentioned VGCC inhibitors,
caused a decrease in the [Ca2+]i response to KCl to 33.1±
2.2% of the control (n = 5) (Fig. 3B), and a concomitant
reduction of the glutamate release to 30.3 ± 2.0% of the
control (n = 5) (Fig. 3A). Genistein further inhibited the
[Ca2+]i response to KCl in the presence of all VGCC in-
hibitors, simultaneously.
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Fig. 3. Comparative effect of genistein and VGCC inhibitors on glutamate release and [Ca2+]i increase in response to KCl. (A) Inhibitory effect of
genistein (Gen) and VGCC inhibitors (VGCC inhib) on glutamate release stimulated by 15 mM KCl. When tested, these drugs were present both in
the pre-incubation and in the reaction medium at the following concentrations: 50M genistein, 500 nM -conotoxin GVIA (CgTx) and/or 100 nM
-agatoxin IVA (Aga). Nitrendipine (Nit, 1M) was applied only in the reaction medium. Results are shown as mean % of control ± S.E.M., for
n = 4–7. (B) Comparison of the inhibitory effects of genistein and VGCC inhibitors on the [Ca2+]i response to 15 mM KCl. The [Ca2+]i measurements
were performed as described in Section 2, in the presence or absence of genistein, nitrendipine, -CgTx GVIA and -Aga IVA, at the concentrations
described previously for glutamate release experiments. Data is presented as mean % control±S.E.M. for n = 4–9. Statistical significance was determined
by one-way ANOVA followed by Newman–Keuls multiple comparison test (∗P < 0.05; ∗∗P < 0.01 and ∗∗∗P < 0.001). Unless otherwise indicated, the
comparison is made between the indicated bar and the bar corresponding to the effect of genistein on its own.
The effects of nitrendipine, -CgTx GVIA and -Aga
IVA on the release of glutamate were due to a direct action
on Ca2+ influx, since glutamate release evoked by 5M
ionomycin was not affected by these drugs (data not shown).
This rules out a non-specific effect of the Ca2+ channel
antagonists at a step downstream of Ca2+ entry.
These results confirm previous reports indicating
P-/Q-type VGCC as the main channels responsible for the
Ca2+ influx leading to glutamate release in the hippocam-
pus, and N-type VGCC and unidentified types of VGCC
as minor contributors (Malva et al., 1995; Ambrósio et al.,
1997). Furthermore, our results suggest that genistein may
Fig. 4. Effect of protein tyrosine phosphatase inhibitors on glutamate release and [Ca2+]i increase evoked by KCl. (A) Effect of dephostatin (Deph)
and sodium orthovanadate (Na3VO4), at the concentration of 100M, on total glutamate release evoked by 15 mM KCl. These phosphatase inhibitors
were present both in the incubation and the reaction medium. Results are expressed as mean % of control± S.E.M. for n = 3. (B) Effect of the protein
tyrosine phosphatase inhibitors mentioned earlier in the basal [Ca2+]i of isolated hippocampal nerve terminals. (C) Effect of protein tyrosine phosphatase
inhibitors on the initial [Ca2+]i response to 15 mM KCl. The changes in [Ca2+]i ([Ca2+]i) were calculated as described in the caption of Fig. 2C.
The results are expressed as mean % control± S.E.M. for n = 3–4. None of the tyrosine phosphatase inhibitors showed statistical significant effects as
determined by one-way ANOVA followed by Dunnett comparison test.
reduce Ca2+ influx and glutamate release following de-
polarization, mainly by partial inhibition of P-/Q-type of
VGCC, but also by inhibiting N-type and unidentified types
of VGCC.
3.4. Protein tyrosine phosphatase inhibitors have no effect
on glutamate release and [Ca2+]i increase in response to
KCl-depolarization of hippocampal nerve terminals
Since the effects of tyrosine kinase inhibitors on glutamate
release and on the [Ca2+]i response to KCl-depolarization
were contradictory, we determined the effect of tyrosine
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phosphatase inhibitors on these KCl-evoked events, in order
to further investigate the involvement of tyrosine phospho-
rylation on glutamate release from hippocampal nerve end-
ings. The tyrosine phosphatase inhibitors dephostatin and
sodium orthovanadate were used at concentrations known
to inhibit protein tyrosine phosphatase activity (Swarup et
al., 1982; Imoto et al., 1993). Dephostatin, at a concen-
tration of 100M, had no significant effect on the glu-
tamate release stimulated by 15 mM KCl (Fig. 4A). The
resting [Ca2+]i and the [Ca2+]i response to 15 mM KCl
were also not significantly affected by 100M dephostatin
(Fig. 4B and C). Furthermore, sodium orthovanadate was
without effect on the basal [Ca2+]i, on the [Ca2+]i increase
evoked by KCl and on the concomitant release of glutamate
(Fig. 4A–C). These results, together with the general lack of
effect of tyrosine kinase inhibitors on glutamate release and
[Ca2+]i response to KCl, suggest that tyrosine phosphoryla-
tion of synaptosomal proteins is not essential for exocytosis
of glutamate-containing vesicles in the hippocampus.
4. Discussion
In the present work, we demonstrated that KCl-depolari-
zation evoked a Ca2+-dependent increase in the phospho-
tyrosine content of hippocampal synaptosomal proteins.
Two proteins of approximate molecular weights of 107
and 44 kDa showed a Ca2+-dependent increase in tyrosine
phosphorylation in response to KCl. A Ca2+-dependent
rise in the tyrosine phosphorylation of several proteins
following depolarization was previously described in rat
forebrain synaptosomes and hippocampal slices (Woodrow
et al., 1992; Barrie et al., 1996; Siciliano et al., 1996). In
spite of the increase in tyrosine phosphorylation following
KCl stimulation, with the exception of genistein, all the
tyrosine kinase and tyrosine phosphatase inhibitors had no
effect on glutamate release and Ca2+ influx stimulated by
KCl-depolarization, in hippocampal synaptosomes. There-
fore, our results strongly suggest that tyrosine phosphoryla-
tion does not affect glutamate release in hippocampal nerve
terminals.
Although, we have not determined the identity of the
tyrosine phosphorylated proteins, previous reports suggest
PYK2 and pp125FAK as strong candidates for the 107 kDa
protein that showed an increase in tyrosine phosphorylation
after KCl-depolarization (Siciliano et al., 1996). The Kv2.1
K+ channel -subunit (105–115 kDa), that can be phospho-
rylated on tyrosine residues, is also a possible candidate for
the 107 kDa protein (Peretz et al., 1999). As for the 44 kDa
protein that showed an increase in its phosphotyrosine con-
tent in response to KCl in our system, it is most likely one
of the MAPK isoforms, p42 or p44. In fact, using an an-
tibody against the dually phosphorylated (activated) form
of MAPK we found that KCl-depolarization activates this
kinase in hippocampal synaptosomes, in a Ca2+-dependent
manner (Pereira et al., 2000).
In contrast to the other tyrosine kinase inhibitors, genis-
tein inhibited the Ca2+-dependent glutamate release from
hippocampal nerve terminals, possibly by acting on Ca2+
influx through partial inhibition of P-/Q-type VGCC, and
by inhibiting N-type and unidentified VGCC. Genistin had
no effect on glutamate release and [Ca2+]i response to KCl.
Nevertheless, the lack of effect of the other tyrosine kinase
inhibitors and tyrosine phosphatase inhibitors on the same
events strongly argue against the specificity of the inhibitory
effects of genistein. This isoflavone was initially reported
as being a specific tyrosine kinase inhibitor, showing in
vitro IC50 of 18–30M, depending on the kinase inhibited
(Akiwama et al., 1987; O’Dell et al., 1991; Akiwama and
Ogawara, 1991). The IC50 values for in vivo inhibition of
tyrosine kinase activity by genistein are quite higher, being
111M for EGF receptor autophosphorylation (Akiwama
and Ogawara, 1991). At this concentration, genistein already
had a nearly maximal effect in glutamate release and Ca2+
influx inhibition in our system (Fig. 2), supporting the lack of
specificity of the effect of genistein in these KCl-stimulated
events.
Genistein was reported to inhibit the activity of other
enzymes besides tyrosine kinases, such as -galactosidase,
DNA topoisomerase I and II, S6 kinase and cAMP phos-
phodiesterase 4, at the same range of concentration used
to inhibit tyrosine kinase activity (Akiwama and Ogawara,
1991; Nichols and Morimoto, 1999). Recently, the list of
genistein non-specific effects has been increasing and it now
includes direct inhibition of voltage-sensitive Na+ chan-
nels (Paillart et al., 1997), cardiac L-type Ca2+ channels
(Chiang et al., 1996), GABAA and glycine receptors (Dunne
et al., 1998; Huang and Dillon, 2000), inhibition of myocyte
delayed-rectifier K+ currents (Washizuka et al., 1998) and
direct activation of cystic fibrosis transmembrane conduc-
tance regulator Cl− channels (French et al., 1997).
In our study, genistein inhibited depolarization-induced
Ca2+ influx and glutamate release, most likely through di-
rect or indirect inhibition of VGCC. This is suggested by
the differential effect of genistein on [Ca2+]i rise mediated
through different types of VGCC (Fig. 3). In fact, genistein
directly inhibits L-type Ca2+ channels in guinea pig ventric-
ular myocytes (Chiang et al., 1996). The non-specific inhi-
bition of K+ channels by genistein (Washizuka et al., 1998)
is another possibility, since depolarization with high extra-
cellular [K+] is driven by inward K+ currents. Therefore,
by inhibiting K+ channels, genistein would reduce Ca2+ in-
flux and the concomitant glutamate release. The direct inhi-
bition of voltage-activated Na+ channels, also reported for
genistein (Paillart et al., 1997), is not a suitable mechanism
for the effects described in this report, since KCl-stimulated
glutamate release and Ca2+ influx are not dependent on Na+
channel activity (Tibbs et al., 1989). However, although the
effect of genistein in these KCl-evoked events is very likely
non-specific, a specific effect through a tyrosine kinase that
is not inhibited by lavendustin A or herbimycin A can not
be entirely ruled out.
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Our present results suggesting that the phosphotyro-
sine content of nerve terminal proteins does not influence
neurotransmitter release in the hippocampus were not ex-
pected based on previous reports. Genistein was shown
to inhibit glutamate release from hippocampal synapto-
somes in a previous study (Mullany et al., 1996), although
neither the specificity of the effect nor the mechanisms
involved were further characterized. The present results
suggest that the effect of genistein reported by Mullany
et al. is independent of tyrosine kinase inhibition. How-
ever, in bovine adrenal chromaffin A cells, tyrosine kinase
inhibitors suppress [3H]noradrenaline ([3H]NA) release
evoked by nicotine, KCl or a Ca2+ ionophore (Cox et al.,
1996). Also, in pheochromocytoma PC12 cells, ionomycin-
and KCl-stimulated [3H]NA release is enhanced by tyro-
sine phosphatase inhibition (Kitamura et al., 2000). These
reports are not necessarily contrary to our results since
the involvement of tyrosine kinases and phosphatases on
exocytosis is likely to depend on cellular context.
On the other hand, a role for tyrosine kinases and phos-
phatases in the regulation of voltage-gated K+ channel
and VGCC is extensively described, suggesting that tyro-
sine phophorylation may contribute to an overall increase
in synaptic excitability currents (Lev et al., 1995; Cataldi
et al., 1996; Gurd, 1997). This contrasts with recent re-
ports proposing Na+ channels as novel targets for tyrosine
kinases and phosphatases, being negatively regulated by
tyrosine phosphorylation (Ratcliffe et al., 2000), or by the
outcome of RTK signaling (Hilborn et al., 1998).
Several studies on the effect of tyrosine kinase and tyro-
sine phosphatase inhibitors on L-, N- and T-type VGCC, us-
ing different neuronal and non-neuronal cell types, suggested
that tyrosine kinases and phosphatases act as positive and
negative modulators of VGCC activity, respectively (Cataldi
et al., 1996; Strauss et al., 1997; Morikawa et al., 1998;
Wijetunge et al., 1998). In our study, genistein was the only
tyrosine kinase inhibitor that showed a notorious inhibitory
effect on Ca2+ influx, probably through a non-specific mech-
anism as discussed above. Herbimycin A also had a small
inhibitory effect on the [Ca2+]i increase stimulated by KCl
that did not influence glutamate release (Fig. 2). Therefore,
our results do not rule out a small contribution of tyrosine
kinase activity on the [Ca2+]i response to depolarization in
hippocampal nerve terminals. The tyrosine phosphatase in-
hibitors, however, had no significant effect on Ca2+ influx
in our system (Fig. 4). A recent report showed a 30–40%
reduction of P-/Q-type Ca2+ currents, but not L- or N-type
Ca2+ currents, by genistein and another tyrosine kinase in-
hibitor, tyrphostin B42 (and not by two of genistein inac-
tive analogues), in hippocampal slices (Potier and Rovira,
1999). Since these results were obtained using whole cell
patch clamp and applying the inhibitors to the whole slice,
they cannot be easily compared with the results we obtained
in our study.
Although our results do not support a meaningful con-
stitutive regulation of the channels involved in neurotrans-
mitter release by tyrosine phosphorylation, tyrosine kinase
activation (or tyrosine phosphatase inhibition) following
depolarization may lead to further tyrosine phosphorylation
of the channels. This could enhance Ca2+ influx during
high frequency pre-synaptic stimulation, resulting in a pos-
itive feedback mechanism. In fact, tyrosine kinase activity
is required for the induction of LTP in the hippocampus
(O’Dell et al., 1991; Huang and Hsu, 1999).
The synaptic vesicle proteins synaptophysin and synapt-
ogyrin are substrates of the tyrosine kinases c-src and c-fyn
(Pang et al., 1988; Stenius et al., 1995; Janz et al., 1999).
Studies with synaptophysin and synaptogyrin knockout mice
suggested an essential but redundant role for these proteins
in the modulation of short- and long-term synaptic plastic-
ity, without being required for neurotransmitter release (Janz
et al., 1999). Although the physiological relevance of tyro-
sine phosphorylation of synaptophysin and synaptogyrin is
still unknown, this associates two of the few known phos-
photyrosine synaptic vesicle proteins with LTP but not with
neurotransmitter release.
In conclusion, we found that although there was an
increase in tyrosine phosphorylation following K+-depolari-
zation of isolated nerve endings, tyrosine kinases and phos-
phatases do not seem to be involved in the modulation
of Ca2+ influx and concomitant glutamate release evoked
by the same stimulus. Unlike the other tyrosine kinase
inhibitors, genistein inhibited Ca2+ influx and glutamate
release, through mechanisms most likely independent of
tyrosine kinase inhibition. This work, together with a vast
list of previous reports, rules out genistein as a suitable tool
to study the involvement of protein tyrosine kinase activity
in cellular events.
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